Imunon Inc (IMNN)
1.44
-0.02
(-1.37%)
USD |
NASDAQ |
May 31, 16:00
1.47
+0.03
(+2.08%)
After-Hours: 20:00
Imunon Research and Development Expense (TTM): 11.96M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 11.96M |
| December 31, 2023 | 11.29M |
| September 30, 2023 | 10.74M |
| June 30, 2023 | 11.17M |
| March 31, 2023 | 11.26M |
| December 31, 2022 | 11.73M |
| September 30, 2022 | 11.72M |
| June 30, 2022 | 11.78M |
| March 31, 2022 | 11.14M |
| December 31, 2021 | 10.62M |
| September 30, 2021 | 10.44M |
| June 30, 2021 | 10.47M |
| March 31, 2021 | 10.86M |
| December 31, 2020 | 11.34M |
| September 30, 2020 | 11.60M |
| June 30, 2020 | 12.78M |
| March 31, 2020 | 13.35M |
| December 31, 2019 | 13.07M |
| September 30, 2019 | 12.34M |
| June 30, 2019 | 10.86M |
| March 31, 2019 | 11.89M |
| December 31, 2018 | 11.87M |
| September 30, 2018 | 12.73M |
| June 30, 2018 | 13.89M |
| March 31, 2018 | 12.34M |
| Date | Value |
|---|---|
| December 31, 2017 | 13.08M |
| September 30, 2017 | 13.49M |
| June 30, 2017 | 14.37M |
| March 31, 2017 | 14.66M |
| December 31, 2016 | 14.62M |
| September 30, 2016 | 14.71M |
| June 30, 2016 | 13.36M |
| March 31, 2016 | 13.59M |
| December 31, 2015 | 14.66M |
| September 30, 2015 | 15.24M |
| June 30, 2015 | 16.98M |
| March 31, 2015 | 16.58M |
| December 31, 2014 | 14.97M |
| September 30, 2014 | 12.56M |
| June 30, 2014 | 10.20M |
| March 31, 2014 | 9.054M |
| December 31, 2013 | 9.364M |
| September 30, 2013 | 10.92M |
| June 30, 2013 | 12.19M |
| March 31, 2013 | 14.28M |
| December 31, 2012 | 15.77M |
| September 30, 2012 | 17.48M |
| June 30, 2012 | 19.36M |
| March 31, 2012 | 20.21M |
| December 31, 2011 | 19.86M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
10.44M
Minimum
Sep 2021
13.35M
Maximum
Mar 2020
11.53M
Average
11.32M
Median
Research and Development Expense (TTM) Benchmarks
| Avalo Therapeutics Inc | 9.89M |
| iBio Inc | 6.401M |
| Ocugen Inc | 36.84M |
| Petros Pharmaceuticals Inc | 3.646M |
| NovaBay Pharmaceuticals Inc | 0.061M |